Cable Hill Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$402K Buy
7,320
+2,282
+45% +$124K 0.04% 110
2024
Q4
$243K Sell
5,038
-3,631
-42% -$185K 0.02% 181
2024
Q3
$500K Buy
8,669
+175
+2% +$9.45K 0.05% 89
2024
Q2
$412K Buy
+8,494
New +$410K 0.04% 104
2023
Q4
Sell
-5,510
Closed -$296K 215
2023
Q3
$296K Buy
5,510
+1,093
+25% +$58.3K 0.04% 123
2023
Q2
$238K Buy
4,417
+71
+2% +$3.82K 0.03% 157
2023
Q1
$237K Sell
4,346
-2,490
-36% -$121K 0.04% 159
2022
Q4
$331K Buy
6,836
+761
+13% +$33.4K 0.06% 120
2022
Q3
$231K Sell
6,075
-169
-3% -$7.53K 0.05% 133
2022
Q2
$312K Buy
+6,244
New +$331K 0.08% 103
2019
Q2
Sell
-5,277
Closed -$234K 605
2019
Q1
$234K Sell
5,277
-1,230
-19% -$52.7K 0.08% 100
2018
Q4
$282K Buy
6,507
+6,273
+2,681% +$277K 0.11% 79
2018
Q3
$10K Sell
234
-75
-24% -$3.2K ﹤0.01% 436
2018
Q2
$12K Hold
309
0.01% 434
2018
Q1
$12K Sell
309
-3,850
-93% -$160K 0.01% 445
2017
Q4
$183K Sell
4,159
-419
-9% -$19.3K 0.08% 90
2017
Q3
$228K Buy
+4,578
New +$222K 0.1% 78

Other funds holding SNY

Cable Hill Partners's SNY Position: Q1 2025 in Review

Cable Hill Partners increased its Sanofi (SNY) stake by 45% in Q1 2025, buying an estimated $124K and bringing the position to 7,320 shares worth $402K. The position accounts for 0.04% of the portfolio, ranked #110.

Cable Hill Partners first reported a position in SNY in Q3 2017 and has held it in 17 quarters since. The position peaked at $500K in Q3 2024. 773 funds tracked by Wall St. Rank hold SNY as of Q1 2025.

  • Cable Hill Partners held 7,320 shares of Sanofi worth $402K as of Q1 2025.
  • Cable Hill Partners bought 2,282 Sanofi shares in Q1 2025, an estimated $124K.
  • Sanofi made up 0.04% of Cable Hill Partners's portfolio in Q1 2025, its #110 holding.
  • Cable Hill Partners first reported a position in Sanofi in Q3 2017 and has held it in 17 quarters since.
  • Cable Hill Partners's Sanofi position peaked at $500K in Q3 2024.
  • 773 funds tracked by Wall St. Rank held Sanofi as of Q1 2025.

Based on Cable Hill Partners's 13F filing for Q1 2025, filed 2 May 2025.